Symbols

BIS

ProShares UltraShort NASDAQ Biotechnology·NASDAQ

--(--)

Key Stats

Assets Under Management

2.70MUSD

Fund Flows (1Y)

645.00KUSD

Dividend Yield

5.53%

Discount/Premium to NAV

0.24%

Shares Outstanding

281.10K

Expense Ratio

0.95%

About ProShares UltraShort NASDAQ Biotechnology

Issuer

ProShare Advisors

Brand

ProShares

Home Page

https://www.proshares.com/our-etfs/leveraged-and-inverse/bis

Inception Date

Apr 7, 2010

Structure

Open-Ended Fund

Index Tracked

NASDAQ Biotechnology Index

Management Style

Passive

Dividend Treatment

Distributes

Distribution Tax Treatment

Ordinary income

Income Tax Type

Capital Gains

Max ST Capital Gains Rate

39.60%

Max LT Capital Gains Rate

20.00%

Primary Advisor

ProShare Advisors LLC

Distributor

SEI Investments Distribution Co.

BIS is one available fund that provides exposure to the biotech space — aiming for daily geared inverse (-2x) exposure to the NASDAQ Biotechnology Index (comprised of companies that are classified as either biotechnology or pharmaceutical). The fund expects to typically hold derivatives and money market instruments. Note: BIS is a tactical tool, it is not a buy-and-hold investment and should not be expected to provide index leverage returns greater than a one-day period.